BiotechTube
Home/Theravance Biopharma/Brett Grimaud
BG

Brett Grimaud

Senior Vice President, General Counsel and Secretary

Theravance Biopharma

Therapeutic Areas

RespiratoryChronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Pipeline

DrugIndicationPhase
YUPELRI® (revefenacin)Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD)Approved
TD-0903Inflammatory Lung Disease (e.g., previously COVID-19)Phase 2
Nebulized Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical
Oral Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical

Leadership Team at Theravance Biopharma

RE
Rick E Winningham
Chief Executive Officer
RF
Rhonda F. Farnum
Senior Vice President, Commercial and Medical Affairs and Chief Business Officer
LS
Laurie Smaldone Alsup
Director
View full Theravance Biopharma profile